Roadblocks for omega 3 as AstraZeneca and Acasti Pharma both report failed trials

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

US-based ingredients supplier Ingredients by Nature (IBN) is partnering  with alfalfa (Medicago sativa) specialist Virentia in preparation for launching a new... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Norway-based GB Rieber VivoMega is spotlighting how its omega 3 softgels can help boost consumer sensory experiences. It is rolling out a softgel sampling program... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

AAK is bringing Progress Biotech’s algae-based DHA to the infant formula market. “This partnership means we can offer infant formula manufacturers a... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Germany-based Aenova is expanding its vegan soft capsule portfolio by adding chewable omega 3 variants. They are based on its existing Aenova VegaGels and are filled... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Sirio is expanding its range of manufacturing techniques that can combat the issue of oxidation during fish-oil based nutraceutical production – something that can... Read More

trans